Immunic (IMUX) Free Cash Flow (2013 - 2026)
Immunic (IMUX) reported Free Cash Flow of -$17.3 million for Q1 2026, up 20.71% on a YoY basis from -$14.3 million in Q1 2025, and up 10.31% sequentially from -$19.3 million in Q4 2025.
Immunic (IMUX) Free Cash Flow (2013 - 2026) Analysis & Trends
Immunic (IMUX) has 14 years of Free Cash Flow data on file, last reported at -$17.3 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow rose 20.71% year-over-year to -$17.3 million; the trailing twelve-month figure through Mar 2026 stood at -$81.4 million (up 1.7% YoY), and the FY2025 full-year result was -$86.0 million, down 1.1% from the prior year.
- Free Cash Flow grew to -$17.3 million in Q1 2026, from -$19.3 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$13.7 million in Q3 2022 to a low of -$24.6 million in Q2 2025.
- A 5-year average of -$19.1 million and a median of -$19.6 million in 2023 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow jumped 45.59% in 2022 and sank 61.82% in 2024, its largest moves.
- Tracing IMUX's Free Cash Flow over 5 years: stood at -$15.1 million in 2022, then climbed by 6.03% to -$14.2 million in 2023, then slumped by 61.82% to -$23.0 million in 2024, then advanced by 16.0% to -$19.3 million in 2025, then increased by 10.31% to -$17.3 million in 2026.
- Business Quant data shows IMUX's Free Cash Flow at -$17.3 million in Q1 2026, -$19.3 million in Q4 2025, and -$20.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Immunic | 11.03 Mn | 11.03 Mn | - | -17.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.30 Mn |
| Mar 31, 2026 | -17.30 Mn |
| Dec 31, 2025 | -19.29 Mn |
| Dec 31, 2025 | -19.29 Mn |
| Sep 30, 2025 | -20.21 Mn |
| Sep 30, 2025 | -20.21 Mn |
| Jun 30, 2025 | -24.65 Mn |
| Jun 30, 2025 | -24.65 Mn |
| Mar 31, 2025 | -21.82 Mn |
| Mar 31, 2025 | -21.82 Mn |
| Dec 31, 2024 | -22.97 Mn |
| Dec 31, 2024 | -22.97 Mn |
| Sep 30, 2024 | -20.85 Mn |
| Sep 30, 2024 | -20.85 Mn |
| Jun 30, 2024 | -17.22 Mn |
| Jun 30, 2024 | -17.22 Mn |
| Mar 31, 2024 | -24.00 Mn |
| Mar 31, 2024 | -24.00 Mn |
| Dec 31, 2023 | -14.19 Mn |
| Dec 31, 2023 | -14.19 Mn |